Menu
Space exploration
Astronomers Discover Houdini-Like Vanishing Act in Space

Most Accurate Robotic Legs Mimic Human Walking Gait

Spaceflight May Extend the Lifespan of Microscopic Worm

Arctic Warming Linked to Combination of Reduced Sea Ice and Global Atmospheric Warming

World's Fastest Camera Used to Detect Rogue Cancer Cells

Keeping the Flu Away: Synthetic Protein Activates Immune System Within Two Hours

'MRI' of the Sun's Interior Motions Challenges Existing Explanations for Sunspots

Sounds of Northern Lights Are Born Close to Ground

Belching Black Hole Proves a Biggie: First Known 'Middleweight' Black Hole

Technique Spots Disease Using Immune Cell DNA

Pompeii-Style Volcanic Ash Fall Preserved 'Nursery' of Earliest Animals

Cutting Daily Sitting Time to Under Three Hours Might Extend Life by Two Years

Greater Diet-Induced Obesity in Rats Consuming Sugar Solution During the Inactive Period

Rising Carbon Dioxide in Atmosphere Also Speeds Carbon Loss from Forest Soils

Climate Change May Lead to Fewer but More Violent Thunderstorms

New Biofuel Process Dramatically Improves Energy Recovery, and Uses Agricultural Waste

Toward Achieving One Million Times Increase in Computing Efficiency

Hubble Unmasks Ghost Galaxies

New Parasitic Coral Reef Crustacean Named After Late Reggae Performer Bob Marley

The Old Primates' Club: Even Male Monkeys Ride Their Fathers' Coattails to Success

Data Storage of Tomorrow: Ferroelectricity On the Nanoscale

One Smart Egg: Birds Sense Day Length and Change Development

Dark Galaxies of the Early Universe Spotted for the First Time

Not So Happy: King Penguins Stressed by Human Presence

Nanodevice Builds Electricity from Tiny Pieces

Transforming Cancer Into a Manageable Illness With Multi-Drug Approach
A Harvard researcher studying the evolution of drug resistance in cancer says that, in a few decades, "many, many cancers could be manageable."

"Many people are dying needlessly of cancer, and this research may offer a new strategy in that battle," said Martin Nowak, a professor of mathematics and of biology and director of the Program for Evolutionary Dynamics. "One hundred years ago, many people died of bacterial infections. Now, we have treatment for such infections -- those people don't have to die. I believe we are approaching a similar point with cancer."

Nowak is one of several co-authors of a paper, published in Nature on June 28, that details how resistance to targeted drug therapy emerges in colorectal cancers and describes a multidrug approach to treatment that could make many cancers manageable, if not curable.

The key, Nowak's research suggests, is to change the way clinicians battle the disease.

Physicians and researchers in recent years have increasingly turned to "targeted therapies" -- drugs that combat cancer by interrupting its ability to grow and spread -- rather than traditional chemotherapy, but such treatment is far from perfect. Most targeted therapies are effective for only a few months before the cancer evolves resistance to the drugs.

The culprit in the colon cancer treatment examined in the Nature paper is the KRAS gene, which is responsible for producing a protein to regulate cell division. When activated, the gene helps cancer cells develop resistance to targeted-therapy drugs, effectively making the treatment useless.

To better understand what role the KRAS gene plays in drug resistance, a team of researchers led by Bert Vogelstein, the Clayton Professor of Oncology and Pathology at the Johns Hopkins Kimmel Cancer Center, launched a study that began by testing patients to determine if the KRAS gene was activated in their tumors. Patients without an activated KRAS gene underwent a normal round of targeted therapy treatment, and the initial results -- as expected -- were successful. Tests performed after the treatment broke down, however, showed a surprising result: The KRAS gene had been activated.

As part of the research, Vogelstein's team analyzed a handful of mutations that can lead to the activation of the KRAS gene. To help interpret those results, they turned to Nowak's team, including mathematicians Benjamin Allen, a postdoctoral fellow in mathematical biology, and Ivana Bozic, a postdoctoral fellow in mathematics.

Analyzing the clinical results, Allen and Bozic were able to mathematically describe the exponential growth of the cancer and determine whether the mutation that led to drug resistance was pre-existing, or whether it occurred after treatment began. Their model was able to predict, with surprising accuracy, the window of time from when the drug is first administered to when resistance arises and the drug begins to fail.

"By looking at their results mathematically, we were able to determine conclusively that the resistance was already there, so the therapy was doomed from the start," Allen said. "That had been an unresolved question before this study. Clinicians were finding that these kinds of therapies typically don't work for longer than six months, and our finding provides an explanation for why that failure occurs."

Put simply, Nowak said, the findings suggest that, of the billions of cancer cells that exist in a patient, only a tiny percentage -- about one in a million -- are resistant to drugs used in targeted therapy. When treatment starts, the nonresistant cells are wiped out. The few resistant cells, however, quickly repopulate the cancer, causing the treatment to fail.

"Whether you have resistance prior to the start of treatment was one of the large, outstanding questions associated with this type of treatment," Bozic said. "Our study offers a quantitative understanding of how resistance evolves, and shows that, because resistance is there at the start, the single-drug therapy won't work."

The answer, Nowak said, is simple: Rather than the one drug used in targeted therapy, treatments must involve at least two drugs.

Nowak isn't new to such strategies. In 1995 he participated in a study, also published in Nature, that focused on the rapid evolution of drug resistance in HIV. The result of that study, he said, was the development of the drug "cocktail" many HIV-positive patients use to help manage the disease.

Such a plan, however, isn't without challenges.

The treatment must be tailored to the patient, and must be based on the genetic makeup of the patient's cancer. Perhaps even more importantly, Nowak said, the two drugs used simultaneously must not overlap: If a single mutation allows the cancer to become resistant to both drugs, the treatment will fail just as the single-drug therapy does.

Nowak estimated that hundreds of drugs might be needed to address all the possible treatment variations. The challenge in the near term, he said, is to develop those drugs.

"This will be the main avenue for research into cancer treatment, I think, for the next decade and beyond," Nowak said. "As more and more drugs are developed for targeted therapy, I think we will see a revolution in the treatment of cancer."

Для печати
Mechanical Engineers Develop an 'Intelligent Co-Pilot' for Cars

Lab-Engineered Muscle Implants Restore Function in Animals

Engineering Technology Reveals Eating Habits of Giant Dinosaurs

Protein Found in Spider Venom Could Treat Muscular Dystrophy

Force of Nature: Defining the Mechanical Mechanisms in Living Cells

Neurons Derived from Cord Blood Cells May Represent New Therapeutic Option

Coastal Populations Are Healthier Than Those Inland, UK Study Finds

Largest Ancient Dam Built by Maya in Central America

World Record: Lightest Material in the World Produced

Infants' Recognition of Speech More Sophisticated Than Previously Known

In Visual Searches, Computer Is No Match for the Human Brain

Musical Glove Improves Sensation, Mobility for People With Spinal Cord Injury

New Evidence Links Immune Irregularities to Autism, Mouse Study Suggests


Menu
The More Gray Matter You Have, the More Altruistic You Are

Hubble Discovers a Fifth Moon Orbiting Pluto

One Step Closer to New Kind of Thermoelectric 'Heat Engine'

Native American Populations Descend from Three Key Migrations, Scientists Say

Trigger for Past Rapid Sea Level Rise Discovered

Skulls Shed New Light On the Evolution of the Cat

Transforming Cancer Into a Manageable Illness With Multi-Drug Approach

The Eyes Don't Have It: New Research Into Lying and Eye Movements

Giant Fossil Turtle from Colombia Round Like Car Tire

Fossil Egg Links Dinosaurs to Modern Birds

Viruses May Be Causing Coral Bleaching and Decline Around the World

Peering Into the Heart of a Supernova: How to Detect a Rapidly Spinning Stellar Core

Physicists Invent 'Spintronic' LED

Newly Isolated 'Beige Fat' Cells Could Help Fight Obesity

Study: Wolverines Need Refrigerators

Solar System Ice: Source of Earth's Water

Attacking Biofilms That Cause Chronic Infections

Discovery of Chemical That Affects Biological Clock Offers New Way to Treat Diabetes

Vaccines Backfire: Veterinary Vaccines Found to Combine Into New Infectious Viruses

Antarctica at Risk from Human Activities

Large, Medically Important Class of Proteins Starts to Yield Its Secrets

Early Human Ancestor, Australopithecus Sediba, Fossils Discovered in Rock

First Ever Videos of Snow Leopard Mother and Cubs in Dens Recorded in Mongolia

Messy Experiment Cleans Up Cornstarch and Water Mystery

Controlling Your Computer With Your Eyes